The Amyloidosis Channel is supported with funding from Prothena (Silver).
The Lymphoma Channel is supported with funding from AstraZeneca (Diamond), BMS (Gold), Johnson & Johnson (Gold), Takeda (Silver) and Galapagos (Bronze).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
SOHO 2024 | Clinical features, complications, and outcomes of familial Waldenström’s macroglobulinemia
Jorge Castillo, MD, Dana-Farber Cancer Institute, Boston, MA, discusses the clinical presentations, complications, and survival outcomes of patients with familial Waldenström’s macroglobulinemia (WM), highlighting how these patients have an increased risk of certain complications, including Bing-Neel Syndrome (BNS) and amyloidosis, but no difference in survival outcome compared to other forms of WM. This interview took place at the Twelfth Annual Meeting of the Society of Hematologic Oncology (SOHO 2024) congress in Houston, TX.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
